$INSP
Inspire Medical Systems, Inc.

2019 Q3 Form 10-Q Financial Statement

#000160955019000043 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $20.86M $18.03M $10.94M
YoY Change 59.81% 64.86% 81.03%
Cost Of Revenue $3.456M $3.094M $2.102M
YoY Change 40.09% 47.19% 52.32%
Gross Profit $17.41M $14.94M $8.836M
YoY Change 64.41% 69.06% 89.37%
Gross Profit Margin 83.43% 82.84% 80.78%
Selling, General & Admin $22.43M $20.27M $12.74M
YoY Change -9.47% 59.11% 74.28%
% of Gross Profit 128.86% 135.69% 144.18%
Research & Development $3.623M $2.846M $1.735M
YoY Change 104.57% 64.03% -0.29%
% of Gross Profit 20.81% 19.05% 19.64%
Depreciation & Amortization $130.0K $110.0K $100.0K
YoY Change 30.0% 10.0% 66.67%
% of Gross Profit 0.75% 0.74% 1.13%
Operating Expenses $26.06M $23.11M $14.47M
YoY Change 71.02% 59.7% 59.92%
Operating Profit -$8.651M -$8.176M -$5.637M
YoY Change 86.08% 45.04% 28.58%
Interest Expense $529.0K $523.0K $550.0K
YoY Change -22.21% -4.91% -244.74%
% of Operating Profit
Other Income/Expense, Net $404.0K $526.0K -$219.0K
YoY Change -1018.18% -340.18%
Pretax Income -$8.247M -$7.650M -$5.856M
YoY Change 75.73% 30.64% 23.03%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.247M -$7.650M -$5.856M
YoY Change 75.73% 30.64% 23.13%
Net Earnings / Revenue -39.53% -42.42% -53.54%
Basic Earnings Per Share
Diluted Earnings Per Share -$344.6K -$322.1K -$274.5K
COMMON SHARES
Basic Shares Outstanding 23.91M shares 23.81M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $151.6M $158.6M $124.0M
YoY Change 25.91% 27.9%
Cash & Equivalents $48.04M $51.27M $121.9M
Short-Term Investments $103.6M $107.4M $2.100M
Other Short-Term Assets $3.200M $5.600M $1.000M
YoY Change 220.0% 460.0%
Inventory $4.675M $3.561M $3.500M
Prepaid Expenses $3.200M $5.596M
Receivables $10.99M $9.465M $4.500M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $170.5M $177.2M $133.0M
YoY Change 31.17% 33.26%
LONG-TERM ASSETS
Property, Plant & Equipment $2.757M $1.826M $900.0K
YoY Change 260.39% 102.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.600M $6.100M
YoY Change
Other Assets $400.0K $400.0K
YoY Change
Total Long-Term Assets $12.76M $8.323M $900.0K
YoY Change 1568.37% 824.78%
TOTAL ASSETS
Total Short-Term Assets $170.5M $177.2M $133.0M
Total Long-Term Assets $12.76M $8.323M $900.0K
Total Assets $183.2M $185.6M $133.9M
YoY Change 40.17% 38.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.800M $2.700M $2.200M
YoY Change 100.0% 22.73%
Accrued Expenses $7.865M $5.980M $4.400M
YoY Change 58.5% 35.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.700M
YoY Change
Total Short-Term Liabilities $12.70M $8.661M $9.300M
YoY Change 67.25% -6.87%
LONG-TERM LIABILITIES
Long-Term Debt $24.50M $24.40M $22.00M
YoY Change -1.21% 10.91%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $24.50M $24.40M $22.00M
YoY Change -1.27% 10.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.70M $8.661M $9.300M
Total Long-Term Liabilities $24.50M $24.40M $22.00M
Total Liabilities $37.17M $33.08M $31.30M
YoY Change 14.69% 5.67%
SHAREHOLDERS EQUITY
Retained Earnings -$171.1M -$162.8M
YoY Change 20.36%
Common Stock $24.00K $24.00K
YoY Change 14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $146.1M $152.5M $102.6M
YoY Change
Total Liabilities & Shareholders Equity $183.2M $185.6M $133.9M
YoY Change 40.17% 38.58%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$8.247M -$7.650M -$5.856M
YoY Change 75.73% 30.64% 23.13%
Depreciation, Depletion And Amortization $130.0K $110.0K $100.0K
YoY Change 30.0% 10.0% 66.67%
Cash From Operating Activities -$2.940M -$12.89M -$6.130M
YoY Change -17.42% 110.28% 52.11%
INVESTING ACTIVITIES
Capital Expenditures -$1.070M -$950.0K -$50.00K
YoY Change 1800.0% 150.0%
Acquisitions
YoY Change
Other Investing Activities $560.0K -$38.06M $4.650M
YoY Change -100.61% -918.49%
Cash From Investing Activities -$500.0K -$39.03M $4.590M
YoY Change -99.46% -950.33% -23050.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0K 1.250M 112.2M
YoY Change 375.0% -98.89% 1122300.0%
NET CHANGE
Cash From Operating Activities -2.940M -12.89M -6.130M
Cash From Investing Activities -500.0K -39.03M 4.590M
Cash From Financing Activities 190.0K 1.250M 112.2M
Net Change In Cash -3.250M -50.67M 110.7M
YoY Change -96.6% -145.77% -2840.1%
FREE CASH FLOW
Cash From Operating Activities -$2.940M -$12.89M -$6.130M
Capital Expenditures -$1.070M -$950.0K -$50.00K
Free Cash Flow -$1.870M -$11.94M -$6.080M
YoY Change -47.47% 96.38% 51.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001609550
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23900730 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23401675 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23900730 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23401675 shares
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1504
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2019Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2018Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38468
dei Entity Registrant Name
EntityRegistrantName
Inspire Medical Systems, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1377674
dei Entity Address Address Line1
EntityAddressAddressLine1
5500 Wayzata Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1600
dei Entity Address City Or Town
EntityAddressCityOrTown
Golden Valley
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55416
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
672-4357
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
INSP
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23909874 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51268000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97288000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
107352000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
90922000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9465000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6667000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
3561000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
2667000 USD
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5596000 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1734000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
177242000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
199278000 USD
CY2019Q2 us-gaap Long Term Investments
LongTermInvestments
6116000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1826000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802000 USD
CY2019Q2 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
381000 USD
CY2018Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
0 USD
CY2019Q2 us-gaap Assets
Assets
185565000 USD
CY2018Q4 us-gaap Assets
Assets
200080000 USD
CY2019Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2681000 USD
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3429000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5980000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7726000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8661000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11155000 USD
CY2019Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
24415000 USD
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
24926000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
33076000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
36081000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
24000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
23000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
315243000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
310941000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
51000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-162829000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146913000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
152489000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
163999000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185565000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
200080000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18032000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10938000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34282000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20980000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3094000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2102000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5948000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4396000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
14938000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
8836000 USD
us-gaap Gross Profit
GrossProfit
28334000 USD
us-gaap Gross Profit
GrossProfit
16584000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2846000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1735000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5449000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3465000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20268000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12738000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39838000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23951000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
23114000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
14473000 USD
us-gaap Operating Expenses
OperatingExpenses
45287000 USD
us-gaap Operating Expenses
OperatingExpenses
27416000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8176000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5637000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16953000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10832000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1036000 USD
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
348000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2122000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
408000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
523000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
550000 USD
us-gaap Interest Expense
InterestExpense
1060000 USD
us-gaap Interest Expense
InterestExpense
1935000 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-5856000 USD
us-gaap Profit Loss
ProfitLoss
-15916000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7650000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5856000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
526000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-219000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1037000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1525000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15916000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12357000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-7650000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15813000 USD
us-gaap Profit Loss
ProfitLoss
-12357000 USD
CY2019Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
35000 USD
CY2018Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
103000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7615000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5856000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12357000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.66
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23753647 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13543558 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23598466 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7448955 shares
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
157416000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
604000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
637000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1389000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-7650000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
102575000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
152489000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
163999000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
770000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
116000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
637000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2780000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
103000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15916000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
152489000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4933000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
200000 USD
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
112040000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2018Q2 insp Stock Issued During Period Value Conversion Of Warrants
StockIssuedDuringPeriodValueConversionOfWarrants
855000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
269000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-5856000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1327000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
386000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
112040000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
insp Stock Issued During Period Value Conversion Of Warrants
StockIssuedDuringPeriodValueConversionOfWarrants
855000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
324000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12357000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
102575000 USD
us-gaap Profit Loss
ProfitLoss
-15916000 USD
us-gaap Profit Loss
ProfitLoss
-12357000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
209000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
188000 USD
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
609000 USD
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
161000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
339000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2780000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
324000 USD
insp Sharebased Compensation Noncash Services
SharebasedCompensationNoncashServices
116000 USD
insp Sharebased Compensation Noncash Services
SharebasedCompensationNoncashServices
0 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-595000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
141000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2801000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
630000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
894000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-122000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4241000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
607000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-745000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-753000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1745000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
227000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23826000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12552000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1233000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
101037000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5138000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
79204000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
10220000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23066000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5023000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
769000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
386000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112041000 USD
insp Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockFromEmployeeStockPurchasePlan
637000 USD
insp Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockFromEmployeeStockPurchasePlan
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
531000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
875000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120427000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46020000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
112898000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97288000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8955000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51268000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121853000 USD
us-gaap Interest Paid Net
InterestPaidNet
1087000 USD
us-gaap Interest Paid Net
InterestPaidNet
893000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
103000 USD
CY2018Q2 insp Reclassification Of Warrant Liability To Additional Paid In Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital
900000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements. We use significant judgment when making estimates related to the allowance for doubtful accounts, inventory reserves, warranty reserves, and the valuations of our common stock prior to our IPO, share-based awards, and certain of our previously outstanding preferred stock warrants. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div>
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
100000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:700;line-height:120%;">Concentration of Credit Risk</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash equivalents, investments, and accounts receivable. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Our investment policy limits investments to certain types of debt securities issued by the U.S. government and its agencies, corporations with investment-grade credit ratings, or commercial paper and money market funds issued by the highest quality financial and non-financial companies. We place restrictions on maturities and concentration by type and issuer. We are exposed to credit risk in the event of a default by the issuers of these securities to the extent recorded on the balance sheets. However, as of June 30, 2019 and December 31, 2018, we limited our credit risk associated with cash equivalents by placing investments with banks we believe are highly creditworthy.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">We believe that the credit risk in our accounts receivable is mitigated by our credit evaluation process, relatively short collection terms, and dispersion of our customer base. We generally do not require collateral, and losses on accounts receivable have historically been within management's expectations.</span></div>
CY2019Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
100000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
100000 USD
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
900000 USD
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
800000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q2 us-gaap Advertising Expense
AdvertisingExpense
4400000 USD
CY2018Q2 us-gaap Advertising Expense
AdvertisingExpense
2500000 USD
us-gaap Advertising Expense
AdvertisingExpense
7900000 USD
us-gaap Advertising Expense
AdvertisingExpense
4700000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1865000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
3561000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1026000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
802000 USD
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2535000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
2667000 USD
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2546000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1601000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
720000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
799000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1826000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 USD
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2019Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5095000 USD
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6490000 USD
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
155000 USD
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
195000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
730000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1041000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5980000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7726000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9188000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
12250000 USD
CY2019Q2 insp Longterm Debt Maturities Repayments Of Principal Thereafter
LongtermDebtMaturitiesRepaymentsOfPrincipalThereafter
3062000 USD
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
24500000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
519000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1026000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
888000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1504000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2043000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
9448000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15428000 USD
CY2019Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000 USD
CY2018Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2019Q1 insp Reclassification Of Warrant Liability To Additional Paid In Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital
900000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1143974 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.65
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2745156 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.64
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
113552 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
53.44
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
478579 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15070 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
35.01
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2365059 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.69
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
103976000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
65204000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1389000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
269000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2780000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
324000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15700000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18032000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10938000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34282000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20980000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2371654 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2295891 shares

Files In Submission

Name View Source Status
0001609550-19-000043-index-headers.html Edgar Link pending
0001609550-19-000043-index.html Edgar Link pending
0001609550-19-000043.txt Edgar Link pending
0001609550-19-000043-xbrl.zip Edgar Link pending
a2019-q2ex10x1.htm Edgar Link pending
a2019-q2ex31x1.htm Edgar Link pending
a2019-q2ex31x2.htm Edgar Link pending
a2019-q2ex32x1.htm Edgar Link pending
a2019-q2ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
insp-20190630.htm Edgar Link pending
insp-20190630.xsd Edgar Link pending
insp-20190630_cal.xml Edgar Link unprocessable
insp-20190630_def.xml Edgar Link unprocessable
insp-20190630_g1.jpg Edgar Link pending
insp-20190630_htm.xml Edgar Link completed
insp-20190630_lab.xml Edgar Link unprocessable
insp-20190630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending